期刊文献+

沙眼衣原体Pgp3蛋白及其抗体在血清学检测中的应用进展

Advances in the application of Chlamydia trachomatis Pgp3 and its antibodies in serological detection
暂未订购
导出
摘要 沙眼衣原体感染已成为全球重要的公共卫生问题。Pgp3是由隐蔽性质粒编码的毒力蛋白,具有高度保守的三聚体结构,通过中和抗菌肽LL-37和激活TNFR1通路在沙眼衣原体致病过程中发挥关键作用。Pgp3蛋白作为免疫优势蛋白,基于Pgp3的血清学检测方法(ELISA/MBA/LISA)显著优于传统MOMP检测。其抗体可持续存在12年以上,是评估既往感染的理想标志物。与输卵管不孕症(aOR=2.6)和盆腔炎(PR=2)显著相关,具有预测深部感染的潜力。本综述系统分析沙眼衣原体Pgp3蛋白结构、致病机制及其抗体评估既往感染和预测深部感染中的应用,为Pgp3在沙眼衣原体感染的预后评估中的临床应用提供理论依据。 Chlamydia trachomatis infection has become a major global public health concern.Pgp3,a virulence protein encoded by a cryptic plasmid,features a highly conserved trimeric structure and plays a pivotal role in C.trachomatis pathogenesis by neutralizing the antimicrobial peptide LL-37 and activating the TNFR1 signaling pathway.As an immunodominant protein,Pgp3-based serological assays(ELISA/MBA/LISA)demonstrate significantly superior performance compared to traditional MOMP detection.Pgp3 antibodies persist for over 12 years,making them ideal markers for assessing past infections.Furthermore,Pgp3 seropositivity is significantly associated with tubal infertility(aOR=2.6)and pelvic inflammatory disease(PR=2.0),highlighting its potential for predicting deep-tissue infections.This review systematically analyzes the structure of the Pgp3 protein,its pathogenic mechanisms,and the application of its antibodies in evaluating past infections and predicting deep infections,thereby providing a theoretical foundation for prognostic evaluation of C.trachomatis infections.
作者 周涵 陈文韬 陈洋 张自岩 郑和平 ZHOU Han;CHEN Wentao;CHEN Yang;ZHANG Ziyan;ZHENG Heping(Dermatology Hospital,Southern Medical University,Southern Medical University,Guangzhou 510091,China;Guangzhou Key Laboratory of Precise Prevention and Control of Sexually Transmitted Diseases,Southern Medical University,Guangzhou 510091,China;Institute for Global Health,Southern Medical University,Guangzhou 510091,China)
出处 《皮肤性病诊疗学杂志》 2025年第8期598-603,共6页 Journal of Diagnosis and Therapy on Dermato-venereology
基金 国家自然科学基金(81974307)。
关键词 沙眼衣原体 Pgp3 血清学检测 既往感染 深部感染 Chlamydia trachomatis Pgp3 serological detection previous infection deep infection
  • 相关文献

参考文献5

二级参考文献40

  • 1Yue Xiao-Li,Gong Xiang-Dong,Li Jing,Zhang Jia-Hui,Gu Heng.Epidemiology of Genital Chlamydial Infection in China in 2019[J].International Journal of Dermatology and Venereology,2020,3(2):86-90. 被引量:6
  • 2Geneva: World Health Organization; 2011.Global prevalence and incidence of selected curable sexually transmitted diseases: Overview and estimates.
  • 3Malhotra M,Sood S,Mukherjee A,et al.Genital Chlamydia trachomatis: an update[J].Indian J Med Res,2013,138(3):303-316.
  • 4Centers for Disease Control and Prevention.Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae,2014[J].MMWR Recommendations and Reports,2014,63( RR-2):1-14.
  • 5Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines,2010[J].MMWR Recommendations and Reports,2010,59(RR-12) :1-110.
  • 6Mourad A,Sweet RL,Sugg N,et al.Relative resistance to erythromycin in Chlamydia trachomatis[J].Antimicrob Agents Chemother,1980,18(5):696-698.
  • 7Jones RB,Van der Pol B,Johnson RB.Susceptibility of Chlamydia trachomatis to trovafloxacin[J].J Antimicrob Chemother,1997,39(Suppl B):63-65.
  • 8Somani J,Bhullar VB,Workowski KA,et al.Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure[J].J Infect Dis,2000,181(4):1421-1427.
  • 9Gomberg MA.Combined treatment of persisting urogenital chlamydia infection with sumamed and interferon alfa [J].Antibiot Khimioter,2002,47(5):12-15.
  • 10American College of Obstetricians and Gynecologists.ACOG Practice Bulletin No.121.Long-acting reversible contraception: Implants and intrauterine devices[J].Obstet Gynecol,2011,118(1):184-196.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部